Eddy
10/26 07:34
By Reuters Staff
1 Min Read
PARIS, Oct 26 (Reuters) - French food company Danone is looking positively into the impact that appetite suppressing anti-obesity drugs could have on its business, Finance Chief Juergen Esser told analysts during a call.
“If anything it will benefit our business,” Esser said, pointing to Danone’s health-focused portfolio and its businesses that include Medical Nutrition.
Reporting by Dominique Vidalon; Editing by Sudip Kar-Gupta
Our Standards: The Thomson Reuters Trust Principles.
Todos los comentarios0Lo más recientePopular